Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing

MeSH terms

• Adolescent
• American Heart Association*
• Attention Deficit Disorder with Hyperactivity / drug therapy
• Attention Deficit Disorder with Hyperactivity / physiopathology
• Cardiovascular Diseases / chemically induced
• Cardiovascular Diseases / drug therapy
• Cardiovascular Diseases / physiopathology
• Central Nervous System Stimulants / adverse effects*
• Child
• Health Planning Guidelines
• Heart Defects, Congenital / drug therapy
• Heart Defects, Congenital / physiopathology
• Heart Diseases / chemically induced
• Heart Diseases / drug therapy*
• Heart Diseases / physiopathology
• Humans
• Monitoring, Physiologic / standards
• Nursing* / standards
• United States